




Searching News Database: transdermal drug delivery
HSMN NewsFeed - 25 Apr 2018
Dermtreat Appoints Nishan de Silva, M.D., as CEO; Establishes North American Headquarters in San Diego
Dermtreat Appoints Nishan de Silva, M.D., as CEO; Establishes North American Headquarters in San Diego
HSMN NewsFeed - 19 Nov 2012
Echo Therapeutics Hires Daniel Sunday as Vice President of Manufacturing and Global Supply Chain
Echo Therapeutics Hires Daniel Sunday as Vice President of Manufacturing and Global Supply Chain
HSMN NewsFeed - 9 Aug 2012
Echo Therapeutics Announces $20 Million Financing with Platinum-Montaur Life Sciences
Echo Therapeutics Announces $20 Million Financing with Platinum-Montaur Life Sciences
HSMN NewsFeed - 18 Aug 2009
Par Pharmaceutical & Aveva Drug Delivery Systems Receive Final Approval to Market Generic Catapres TTS(R)
Par Pharmaceutical & Aveva Drug Delivery Systems Receive Final Approval to Market Generic Catapres TTS(R)
HSMN NewsFeed - 15 Jun 2009
DJO Incorporated Announces Sale of Empi Therapy Solutions Catalog Business to Patterson Medical
DJO Incorporated Announces Sale of Empi Therapy Solutions Catalog Business to Patterson Medical
HSMN NewsFeed - 29 Sep 2008
Noven Names Peter Amanatides as Vice President - Quality Assurance & Quality Control
Noven Names Peter Amanatides as Vice President - Quality Assurance & Quality Control
HSMN NewsFeed - 23 Sep 2008
Vyteris Announces Growth Initiative Through Expanded Business Development Team
Vyteris Announces Growth Initiative Through Expanded Business Development Team
HSMN NewsFeed - 30 Jul 2008
Banner Pharmacaps Receives FDA Approval for Valproic Acid Delayed Release Softgel Capsules
Banner Pharmacaps Receives FDA Approval for Valproic Acid Delayed Release Softgel Capsules
HSMN NewsFeed - 14 Jul 2008
Noven Names Joel Lippman, M.D. as Vice President - Clinical Development & Chief Medical Officer
Noven Names Joel Lippman, M.D. as Vice President - Clinical Development & Chief Medical Officer
HSMN NewsFeed - 8 Jul 2008
Agile Therapeutics Appoints Senior Executive Jeffrey Frick as Chief Business Officer
Agile Therapeutics Appoints Senior Executive Jeffrey Frick as Chief Business Officer
HSMN NewsFeed - 12 Jun 2008
Lilly and TransPharma Medical Announce Licensing and Development Agreement
Lilly and TransPharma Medical Announce Licensing and Development Agreement
HSMN NewsFeed - 29 Apr 2008
Noven Appoints Peter C. Brandt as President, Chief Executive Officer & Director
Noven Appoints Peter C. Brandt as President, Chief Executive Officer & Director
HSMN NewsFeed - 26 Dec 2007
Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed Release Capsules
Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed Release Capsules
HSMN NewsFeed - 30 Oct 2007
New Therapies Emerging to Challenge Pain Management for Transdermal Patch Growth
New Therapies Emerging to Challenge Pain Management for Transdermal Patch Growth
HSMN NewsFeed - 23 Oct 2007
FDA Issues Approvable Letter for Stavzor(TM) Delayed Release Valproic Acid Capsules
FDA Issues Approvable Letter for Stavzor(TM) Delayed Release Valproic Acid Capsules
HSMN NewsFeed - 10 Oct 2007
NuPathe Inc. Names Jerry McLaughlin as Vice President of Commercial Operations
NuPathe Inc. Names Jerry McLaughlin as Vice President of Commercial Operations
HSMN NewsFeed - 1 Oct 2007
Valeant Pharmaceuticals to Partner with ASCEND Therapeutics to Promote Migranal(R) to OB/GYNs
Valeant Pharmaceuticals to Partner with ASCEND Therapeutics to Promote Migranal(R) to OB/GYNs
HSMN NewsFeed - 26 Sep 2007
Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
HSMN NewsFeed - 4 Sep 2007
Transdermal Patch Growth Relying on Improved Designs, Enhanced Manufacturing Methods
Transdermal Patch Growth Relying on Improved Designs, Enhanced Manufacturing Methods
HSMN NewsFeed - 2 Aug 2007
Vyteris Announces Appointment of Anthony J. Cherichella as Chief Financial Officer
Vyteris Announces Appointment of Anthony J. Cherichella as Chief Financial Officer
HSMN NewsFeed - 10 Jul 2007
Noven to Acquire JDS Pharmaceuticals, Expanding Business Model & Broadening Product Pipeline
Noven to Acquire JDS Pharmaceuticals, Expanding Business Model & Broadening Product Pipeline
HSMN NewsFeed - 3 May 2007
Successful Human Clinical Trial of Chrono Therapeutic's Drug/Device Combination Product - ChronoDose(TM)
Successful Human Clinical Trial of Chrono Therapeutic's Drug/Device Combination Product - ChronoDose(TM)
HSMN NewsFeed - 19 Mar 2007
New Phase IV Clinical Study Indicates LidoSite(R) Provides Rheumatology Patients Superior Pain Relief
New Phase IV Clinical Study Indicates LidoSite(R) Provides Rheumatology Patients Superior Pain Relief
HSMN NewsFeed - 31 Jan 2007
NexMed Announces Patient Dosing in Phase 3 Program for Anti-Fungal Product
NexMed Announces Patient Dosing in Phase 3 Program for Anti-Fungal Product
HSMN NewsFeed - 29 Jun 2006
Noven Confirms Availability of Daytrana(TM) Methylphenidate Transdermal System
Noven Confirms Availability of Daytrana(TM) Methylphenidate Transdermal System
HSMN NewsFeed - 26 Jun 2006
NexMed Announces Termination of Alprox-TD Agreement With Schering AG and Provides Operational Update
NexMed Announces Termination of Alprox-TD Agreement With Schering AG and Provides Operational Update
HSMN NewsFeed - 25 May 2006
Agile Therapeutics Closes $12 Million Financing for Development of a Low Estrogen Dose Contraceptive Patch
Agile Therapeutics Closes $12 Million Financing for Development of a Low Estrogen Dose Contraceptive Patch
HSMN NewsFeed - 23 May 2006
ALZA Corporation Receives FDA Approval for IONSYS(TM) (Fentanyl Iontophoretic Transdermal System)
ALZA Corporation Receives FDA Approval for IONSYS(TM) (Fentanyl Iontophoretic Transdermal System)
HSMN NewsFeed - 9 May 2006
Sontra Medical Introduces Generation 2.0 SonoPrep(R) Skin Permeation Device
Sontra Medical Introduces Generation 2.0 SonoPrep(R) Skin Permeation Device
HSMN NewsFeed - 6 Apr 2006
Noven Announces FDA Approval of Daytrana(TM) Methylphenidate Transdermal System
Noven Announces FDA Approval of Daytrana(TM) Methylphenidate Transdermal System
HSMN NewsFeed - 21 Mar 2006
Neuro-Hitech Pharmaceuticals, Inc. Signs Alzheimer's Transdermal Development Agreement with Xel
Neuro-Hitech Pharmaceuticals, Inc. Signs Alzheimer's Transdermal Development Agreement with Xel
HSMN NewsFeed - 10 Mar 2006
FDA Declares Daytrana(TM) NDA Resubmission to Be Complete Class I Response
FDA Declares Daytrana(TM) NDA Resubmission to Be Complete Class I Response
HSMN NewsFeed - 10 Feb 2006
Mylan Laboratories Appoints Carolyn Myers, Ph.D., President of Mylan Technologies Inc.
Mylan Laboratories Appoints Carolyn Myers, Ph.D., President of Mylan Technologies Inc.
HSMN NewsFeed - 7 Feb 2006
Sontra Medical Introduces Generation 1.75 SonoPrep(R) Skin Permeation Device
Sontra Medical Introduces Generation 1.75 SonoPrep(R) Skin Permeation Device
HSMN NewsFeed - 1 Feb 2006
Sontra Medical Serves Patent Infringement Notice for Dermisonics' Transdermal Insulin Delivery System
Sontra Medical Serves Patent Infringement Notice for Dermisonics' Transdermal Insulin Delivery System
Additional items found! 72

Members Archive contains
72 additional stories matching:
transdermal drug delivery
(Password required)
transdermal drug delivery
(Password required)